She received her B.S. in Nursing from the University of Iowa, her M.S. in Pediatric Nursing (Neonatal Nurse Practitioner Program) from the University of Wisconsin, and her Ph.D. in Nursing (Communities and Organizations) from the University of Colorado Health Sciences Center.
Don Elliman is chancellor of the University of Colorado Denver and Anschutz Medical Campus and former executive director of the Charles C. Gates Center for Regenerative Medicine.
From June 2009 to January 2011, Elliman served as chief operating officer for the State of Colorado, assisting the Governor in the management of State agencies. He was also the chair of the Colorado Recovery Accountability Board, established in March of 2009, with responsibilities for oversight of spending in Colorado under the American Recovery and Reinvestment Act. His previous position with the state was as executive director of the Colorado Office of Economic Development and International Trade from 2007 to 2009, where he oversaw a wide range of economic development activities, including domestic and international business development, small business programs, as well as the Colorado Tourism Office and the Colorado Economic Development Commission.
Prior to his government service, Elliman was president of Kroenke Sports Enterprises, where he oversaw all business activities of the company, including The Pepsi Center, The Denver Nuggets and The Colorado Avalanche, as well as several other professional sports teams and entertainment facilities. Prior to his time at Kroenke, Elliman worked at Time Warner for 32 years, retiring as an executive vice president of Time Inc. Other positions he held included publisher of People Magazine and president of Sports Illustrated. He also was president of Time’s consolidated advertising sales group, which had 900 employees and more than $2 billion in annual revenue.
Elliman serves on the boards of The Gates Family Foundation, The Children’s Hospital (where he was one of the chairs of the successful fundraising drive to relocate Children’s to the Anschutz Medical Campus), and Middlebury College.
Elliman graduated from Middlebury College with a B.A. in economics.
William R. Hiatt, MD, is the Novartis Foundation endowed professor for cardiovascular research at the University of Colorado School of Medicine, Division of Cardiology with a clinical and research focus in vascular medicine. He is president of CPC Clinical Research which is a university-affiliated, non-profit cardiovascular and clinical trials research organization.
Active in many national societies, Dr Hiatt is a past-president of the Society for Vascular Medicine and is a fellow in the American Heart Association and the American College of Physicians. He is the immediate past chair of the American Heart Association Peripheral Vascular Disease Council. Dr Hiatt serves on the editorial board as an associate editor for the Journal of Vascular Medicine, the Cochrane Review Group and is guest editor for Circulation and the Journal of the American College of Cardiology. Dr Hiatt is a past chairman of the United States Food and Drug Administration Cardiovascular and Renal Advisory Committee (2003-08). He is currently a member of the FDA Endocrinologic and Metabolism Advisory Committee (guest member 2010-2012 and full member 2013-2016). He has received two outstanding medical student teacher awards and has been elected several times as Best Doctors in America (most recently in 2012). In 2008 he received the Robert W. Schrier Award of Excellence from the Department of Medicine, University of Colorado and he received the Julius H. Jacobson II, MD Physician Excellence Award from the Vascular Disease Foundation.
Research activities include studies evaluating the pathophysiology and epidemiology of peripheral artery disease, mechanisms of supervised exercise as an effective treatment modality for claudication, and numerous clinical trials to develop new therapies for claudication and critical leg ischemia. His research at the CPC has pioneered new methods to control endpoint variability in clinical trials. Dr. Hiatt has 185 peer-reviewed publications. Current trial focus is in stem cell therapy to treat claudication (CPC providing full trial service) and critical leg ischemia (chair of steering committee). He is also running several wound healing trials using stem cell products.
Dr. Hiatt was born in Denver, Colorado in 1950, received his medical degree cum laude from the University of Colorado School Of Medicine in 1976, and was elected to the Alpha Omega Alpha medical society. He completed his residence at Boston University Hospital, Boston, Massachusetts, and the University of Colorado Health Sciences Center in 1979. He was a fellow in internal medicine and vascular medicine at the University of Colorado from 1979 to 1981, and then joined the University of Colorado faculty in 1981.
The CPC is a global, full service clinical trials organization in cardiovascular medicine that directs study design and provides academic oversight of trials of drugs, biologic agents and device therapies for peripheral artery disease. Current funded work includes several initiatives to evaluate the safety and efficacy of stem cells in the treatment of severe peripheral artery disease. The CPC also has funding from the State of Colorado to screen and navigate citizens at high risk for cardiovascular disease into appropriate preventive health care.
Wayne Hutchens served as president and CEO of the University of Colorado Foundation, April 2006 – March 2012 and executive director for the CU Real Estate Foundation, April 2009 – March 2012. Prior to these positions, Hutchens spent 29 years in the banking industry where he oversaw two successful mergers, and retired as chairman of Chase Bank Colorado. He is a 1967 graduate of the University of Colorado at Boulder’s School of Business and has done graduate study at Syracuse University and the University of Colorado. He is a graduate of the Stonier Graduate School of Banking.
Wayne has been active in community service and has chaired the boards of the Denver Museum of Nature and Science, the Colorado Council for Economic Education, and the Colorado Outward Bound School. He also has served as a board member of the Boulder Community Hospital, the Metro Denver Chamber of Commerce, and the Samaritan Institute, and he served a four-year term on the city council for the City of Boulder. He is currently a member of the Colorado Forum, a trustee of the Denver Museum of Nature and Science, a director of Children’s Colorado Hospital, a director of AMG National Trust Bank and is an elder in the Presbyterian Church.
An avid climber, Wayne is a member of the Colorado Mountain Club and the American Alpine Club. He has scaled all 54 Fourteeners in Colorado and numerous other peaks around the world, including Mt. Kilimanjaro in Africa and Mt. Elbrus in Russia. He and his wife Joyce, also a CU-Boulder graduate, have been married for 47 years and have two grown sons, both CU-Boulder graduates.
Mr. Provenzano has over 30 years of experience in the Electronics Industry in sales, marketing, engineering and executive management. Greg is Vice President Global Engineering for Arrow Electronics. He has previously served as President WPG Americas, co founder and CEO of Octera Solutions (now a Macnica company) and Senior Vice President and Regional President of Memec Americas (now an AVNET Electronics company).
Greg holds a Bachelors Degree in Geology from the University of California, Santa Barbara, and an M.B.A. from Pepperdine University.
Kevin is a Colorado native and a long-time member of the Denver business community having worked at Price Waterhouse and RBC Capital Markets (formerly Daniels & Associates) for the past 25 years. While at RBC Capital Markets, Mr. Reidy provided investment banking advisory services to the telecom industry with a focus on wireless communications. He facilitated more than 70 telecom transactions with an aggregate deal values exceeding $3 billion. Mr. Reidy is a graduate of the business school at the University of Colorado, where he earned a bachelor’s degree in accounting in 1987. His community leadership roles include a very active member of the board of directors of Children’s Hospital Colorado and a trustee of the University of Colorado Foundation.
Kevin lives in Denver with his wife Ann and their four children. He and his family are avid skiers and enjoy numerous activities afforded by the Colorado lifestyle.
Dan Ritchie, Co-Chair
Daniel L. Ritchie has served as chairman and chief executive officer of The Denver Center for the Performing Arts since January 2007. Prior to that, he was chancellor of the University of Denver from 1989 to 2005, where he led the rebuilding and renewal of the University. Ritchie also served as the University’s chairman of the board from 2005 to 2007.
Ritchie has held several corporate executive positions, including executive vice president of MCA Universal and chief executive officer of Westinghouse Broadcasting.
In addition to serving as co-chair of the Gates Center Community Advisory Board, he is president of the Temple Hoyne Buell Foundation. He also serves on the boards of the Daniels Fund and the Denver Art Museum Foundation, and is chairman emeritus and honorary member of the Board of the Central City Opera House Association.
His awards include: The Citizen of the West Award, given by the National Western Stock Show to an individual who exemplifies the spirit and determination of the Western pioneer; the National Samaritan Institute Award; Outstanding Philanthropist at National Philanthropy Day; the National Human Relations Award from the American Jewish Committee; the Community Cultural Enrichment Award from the Mizel Museum of Judaica, the Woodrow Wilson Award for Public Service and the Ethical Leadership Award from the University of Denver. He is a Laureate member of the Colorado Business Hall of Fame.
He holds undergraduate and MBA degrees from Harvard University.
In January 2007, Dennis Roop was named director of new program in Regenerative Medicine and Stem Cell Biology at the University of Colorado-Denver. He is also professor of dermatology and holds the Charles C. Gates Chair of Regenerative Medicine and Stem Cell Biology. Under his leadership, the Stem Cell Program achieved recognition as a Center by the University of Colorado-Denver administration, in March 2010.
Prior to joining the University of Colorado-Denver, Roop was professor of molecular and cellular biology and dermatology and director of the Center for Cutaneous Molecular Biology at the Baylor College of Medicine. From 1980 to 1988, he was with the National Cancer Institute, National Institutes of Health, where he rose to the rank of senior investigator. He had been a postdoctoral fellow at the Baylor College of Medicine from 1977 to 1980.
Roop is one of the first investigators to begin using molecular techniques to study how the skin forms during normal embryonic development. He has identified many of the genes required for normal skin development and discovered that defects in some of these genes cause inherited skin diseases characterized by a very fragile skin, which blisters easily and may result in neonatal death.
His current research is focused on generating induced pluripotent stem (iPS) cells from patients with inherited skin diseases, genetically correcting these cells and differentiating them into a skin stem cell lineage which can be returned to the same patient as an autograft.
Roop is the recipient of several awards including: a Max Plank Research Award from the Alexander von Humboldt Foundation (1991), the William Montagna Award from the Society for Investigative Dermatology (1992), the Michael E. DeBakey, M.D., Excellence in Research Award (2001), the CE.R.I.E.S. Research Award (2002), the Tanioku Kihei Memorial Award from the Japanese Society for Investigative Dermatology (2003), the Rene Touraine Foundation Award (2005), and the Stephen Rothman Memorial Award from the Society for Investigative Dermatology (2010), the Society's highest award presented annually to an individual who has distinctly altered the course and image of dermatology or its allied fields. He has served on the Advisory Council at the National Institute of Arthritis and Musculoskeletal and Skin Diseases and he is a former President of the Society for Investigative Dermatology. He was elected to the Berea College Board of Trustees in October 2009. The NIH has continuously supported his research efforts since 1989. He is the author of more than 250 peer-reviewed publications.
He received a B.A. in Biology from Berea College, Berea, KY in 1969 and a M.S. and Ph.D. in Microbiology from the University of Tennessee, Knoxville, TN in 1972 and 1977, respectively.
Wagner (Wag) J. Schorr, MD received his B.S. from the University of Arizona, and earned his M.D. at the University of Colorado, where he studied under transplant pioneer, Thomas Starzl, MD, who performed the first successful human liver transplant in 1963. Dr. Schorr in 1967-68, was instrumental in introducing kidney transplant in the United Kingdom. Among his numerous appointments include Senior Registrar, Renal Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, U.K.; Chief of Medicine, Presbyterian Medical Center, Denver, CO; President, Medical Advisory Board, National Kidney Foundation; Clinical Professor of Medicine, University of Colorado; Founder, Colorado Organ Recovery System; Medical Director/Consultant, Columbia/HealthOne; and the University of Colorado Medical School Admissions Committee, on which he currently serves. Dr. Schorr has also held a number of Board positions, including HealthOne, Colorado Health Foundation, Arts Students’ League of Denver, Denver Country Club, Third Way and the Axion Medical Advisory Board.
Ann Sperling served most recently in two successive roles at Jones Lang LaSalle Incorporated first as Chief Operating Officer for the Americas region and then as President, Markets West. Prior to that, Sperling was Managing Director and the chief operating executive at Catellus Development Group, a wholly owned company of ProLogis. She completed a 25-year career at Trammell Crow Company during which she rose from her first job in retail leasing to become Senior Managing Director and Area Director for its Rocky Mountain region. Over her career, she has been involved in most core real estate services for corporate and investor clients, including tenant representation, agency leasing, investment sales, outsourcing, project management, facilities management, property management, construction and commercial development. She has had extensive experience in public and private company governance, operations, financial performance and new business development.
Sperling has also committed herself to a number of civic and community activities. These include serving as Treasurer and Finance Committee Chair of the Board of Directors of The Children's Hospital. She has also held leadership roles with the Colorado Outward Bound School, National Association of Industrial and Office Properties (NAIOP), the Urban Land Institute (ULI) and the International Council of Shopping Centers (ICSC). She has been honored by the National Association of University Women, and she received the 2008 Commercial Real Estate Women (CREW) Denver's Women of Influence Award. She has also been appointed to several civic advisory groups including the Business Advisory Committee to Governor Bill Ritter and the mayor’s Downtown Revolving Loan Fund.
A graduate of Tufts University with a degree in biology and psychology, Sperling earned her MBA at Harvard University.
Diane Wallach, Co-Chair
Diane G. Wallach is a manager and president of Cody Resources LP, a real asset investment company that focuses on energy and agribusiness. She also serves as manager of Gates Capital Partners, LLC and board chair of Bear Creek Inc., a private trust company. Previously, she worked for Gates Rubber Company, Gould Deltec, and Citibank.
Wallach’s community service includes current positions as trustee of the Colorado-based Gates Family Foundation and the Gates Frontiers Fund, the latter of which made a gift to the University of Colorado in memory of her father, establishing the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology. She also serves as an advisory board member for IAALS (University of Denver’s Institute for the Advancement of the American Legal System); and trustee of Cardigan Mountain School. Previously, Wallach served on the boards of Children’s Hospital Colorado, Colorado Outward Bound School, Denver Art Museum Foundation, Colorado Zoological Trust and YouthBiz, Inc.
Wallach earned both her bachelor’s degree in human biology (1976) and master’s degree in business administration (1983) from Stanford University.